Skip to main content

Effectiveness of Intraarterial Administration of Fasudil Hydrochloride for Preventing Symptomatic Vasospasm After Subarachnoid Hemorrhage

  • Chapter
  • First Online:
Neurovascular Events After Subarachnoid Hemorrhage

Abstract

Objective: We examined the effect of intraarterial administration of fasudil hydrochloride (IAFC), a Rho kinase inhibitor, for the prevention of symptomatic vasospasm after SAH by evaluating cerebral circulation.

Methods: We evaluated IAFC cases of 57 sides of 38 patients (12 men and 26 women, average age 60.2 years old) diagnosed with aneurysmal subarachnoid hemorrhage (SAH) from February 2012 to November 2012. All cases were treated by clipping or coil embolization within 48 h after onset. Indication for IAFC was the existence of a spastic change on follow-up digital subtraction angiography (DSA) compared with that of onset.

Results: Clipping was performed in 30 cases and coil embolization in 8 cases. IAFC was performed an average of 6.6 days after onset. Color gradient mapping demonstrated reduction of the circulation time after IAFC compared with before IAFC on 39 sides, no change on 15 sides, and extension on 3 sides. Average arterial circulation time before IAFC was 2.25 ± 0.57 s and after IAFC was 1.95 ± 0.55 s. IAFC significantly shortened average arterial circulation (P = 0.005). No case developed symptomatic vasospasm after IAFC.

Conclusion: IAFC significantly reduced the cerebral circulation time after aneurysmal SAH and might be effective for the prevention of symptomatic vasospasm.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

eBook
USD 16.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Similar content being viewed by others

References

  1. Ingall T, Asplund K, Mahonen M, Bonita R (2000) A multinational comparison of subarachnoid hemorrhage epidemiology in the WHO MONICA stroke study. Stroke 31:1054–1061

    Article  PubMed  CAS  Google Scholar 

  2. Inoue M, Sasaki T, Takazawa H, Morita T, Narisawa A, Saito A, Midorikawa H, Nishijima M (2013) Symptomatic vasospasm in elderly patients with aneurysmal subarachnoid hemorrhage: comparison with nonelderly patients. Acta Neurochir Suppl 115:281–284

    PubMed  Google Scholar 

  3. Iseda T, Nakano S, Yoneyama T, Ikeda T, Moriyama T, Sameshima T, Goya T, Wakisaka S (2000) Angiographic cerebral circulation time before and after endovascular therapy for symptomatic vasospasm. Clin Radiol 55:679–683

    Article  PubMed  CAS  Google Scholar 

  4. Ito H, Inugami A, Shishido F, Okudera T, Ogawa T, Hatazawa J, Fujita H, Shimosegawa E, Kanno I, Fukuda H (1994) Circulation time determined by carotid angiography in patients with chronic internal carotid artery occlusion: Comparison with cerebral blood flow and oxygen metabolism measured by PET [in Japanese]. Kaku Igaku 31:1193–1199

    PubMed  CAS  Google Scholar 

  5. Kim I, Leinweber BD, Morgalla M, Butler WE, Seto M, Sasaki Y, Peterson JW, Morgan KG (2000) Thin and thick filament regulation of contractility in experimental cerebral vasospasm. Neurosurgery 46:440–446

    Article  PubMed  CAS  Google Scholar 

  6. Ohkuma H, Manabe H, Tanaka M, Suzuki S (2000) Impact of cerebral microcirculatory changes on cerebral blood flow during cerebral vasospasm after aneurysmal subarachnoid hemorrhage. Stroke 31:1621–1627

    Article  PubMed  CAS  Google Scholar 

  7. Okawara SH, Kimura J, Hahn JY (1974) Cerebral circulation time with ruptured intracranial aneurysms. J Neurosurg 41:415–420

    Article  PubMed  CAS  Google Scholar 

  8. Pradilla G, Thai QA, Legnani FG, Hsu W, Kretzer RM, Wang PP, Tamargo RJ (2004) Delayed intracranial delivery of a nitric oxide donor from a controlled-release polymer prevents experimental cerebral vasospasm in rabbits. Neurosurgery 55:1393–1400

    Article  PubMed  Google Scholar 

  9. Sasaki T, Kodama N, Kawakami M, Sato M, Asari J, Sakurai Y, Watanabe K, Onuma T, Matsuda T (2000) Urokinase cisternal irrigation therapy for prevention of symptomatic vasospasm after aneurysmal subarachnoid hemorrhage: a study of urokinase concentration and the fibrinolytic system. Stroke 31:1256–1262

    Article  PubMed  CAS  Google Scholar 

  10. Sato M, Tani E, Fujikawa H, Kaibuchi K (2000) Involvement of Rhokinase-mediated phosphorylation of myosin light chain in enhancement of cerebral vasospasm. Circ Res 87:195–200

    Article  PubMed  CAS  Google Scholar 

  11. Satoh S, Yamaguchi T, Hitomi A, Sato N, Shiraiwa K, Ikegaki I, Asano T, Shimokawa H (2002) Fasudil attenuates interstitial fibrosis in rat kidneys with unilateral ureteral obstruction. Eur J Pharmacol 455:169–174

    Article  PubMed  CAS  Google Scholar 

  12. Satoh S, Hitomi A, Ikegaki I, Kawasaki K, Nakazono O, Iwasaki M, Mohri M, Asano T (2010) Amelioration of endothelial damage/dysfunction is a possible mechanism for the neuroprotective effects of Rho-kinase inhibitors against ischemic brain damage. Brain Res Bull 81:191–195

    Article  PubMed  CAS  Google Scholar 

  13. Shibuya M, Suzuki Y, Sugita K, Saito I, Sasaki T, Takakura K, Nagata I, Kikuchi H, Takemae T, Hidaka H (1992) Effect of AT877 on cerebral vasospasm after aneurismal subarachnoid hemorrhage. J Neurosurg 76:571–577

    Article  PubMed  CAS  Google Scholar 

  14. Shibuya M, Hirai S, Seto M, Satoh S, Ohtomo E (2005) Effects of fasudil in acute ischemic stroke: results of a prospective placebo-controlled double-blind trial. J Neurol Sci 238:31–39

    Article  PubMed  CAS  Google Scholar 

  15. Siasios I, Kapsalaki EZ, Fountas KN (2013) Cerebral vasospasm pharmacological treatment: an update. Neurol Res Int. doi:10.1155/2013/571328

    PubMed  PubMed Central  Google Scholar 

  16. Suzuki Y, Shibuya M, Satoh S, Sugimoto Y, Takakura K (2007) A postmarketing surveillance study of fasudil treatment after aneurismal subarachnoid hemorrhage. Surg Neurol 68:126–132

    Article  PubMed  Google Scholar 

  17. Suzuki Y, Shibuya M, Satoh S, Sugiyama H, Seto M, Takakura K (2008) Safety and efficacy of fasudil monotherapy and fasudil-ozagrel combination therapy in patients with subarachnoid hemorrhage: sub-analysis of the post-marketing surveillance study. Neurol Med Chir 48:241–248

    Article  Google Scholar 

  18. Udoetuk JD, Stiefel MF, Hurst RW, Weigele JB, LeRoux P (2007) Admission angiographic cerebral circulation time may predict subsequent angiographic vasospasm after aneurismal subarachnoid hemorrhage. Neurosurgery 61:1152–1161

    Article  PubMed  Google Scholar 

  19. Yamamoto S, Watanabe M, Uematsu T, Takasawa K, Nukata M, Kinoshita N (2004) Correlation of angiographic circulation time and cerebrovascular reserve by acetazolamide-challenged single photon emission CT. AJNR Am J Neuroradiol 25:242–247

    PubMed  Google Scholar 

Download references

Conflict of Interest Statement

We declare that we have no conflict of interest.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Atsushi Saito MD, PhD .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2015 Springer International Publishing Switzerland

About this chapter

Cite this chapter

Saito, A. et al. (2015). Effectiveness of Intraarterial Administration of Fasudil Hydrochloride for Preventing Symptomatic Vasospasm After Subarachnoid Hemorrhage. In: Fandino, J., Marbacher, S., Fathi, AR., Muroi, C., Keller, E. (eds) Neurovascular Events After Subarachnoid Hemorrhage. Acta Neurochirurgica Supplement, vol 120. Springer, Cham. https://doi.org/10.1007/978-3-319-04981-6_50

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-04981-6_50

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-04980-9

  • Online ISBN: 978-3-319-04981-6

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics